Bone Biologics Corp. (BBLG)
0.5615
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 16:00
0.5615
0.00 (0.00%)
After-Hours: 17:28
Bone Biologics Total Liabilities (Quarterly) : 0.512M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.512M |
| March 31, 2026 | 0.3094M |
| December 31, 2025 | 0.4186M |
| September 30, 2025 | 0.3343M |
| June 30, 2025 | 0.4061M |
| March 31, 2025 | 0.2512M |
| December 31, 2024 | 0.3777M |
| September 30, 2024 | 0.2734M |
| June 30, 2024 | 0.2845M |
| March 31, 2024 | 0.1646M |
| December 31, 2023 | 0.8314M |
| September 30, 2023 | 1.183M |
| June 30, 2023 | 1.930M |
| March 31, 2023 | 4.011M |
| December 31, 2022 | 2.548M |
| September 30, 2022 | 0.7995M |
| June 30, 2022 | 0.0706M |
| March 31, 2022 | 0.0549M |
| December 31, 2021 | 0.0999M |
| September 30, 2021 | 15.18M |
| June 30, 2021 | 14.62M |
| March 31, 2021 | 14.20M |
| December 31, 2020 | 13.69M |
| September 30, 2020 | 13.24M |
| June 30, 2020 | 12.85M |
| Date | Value |
|---|---|
| March 31, 2020 | 12.47M |
| December 31, 2019 | 11.90M |
| September 30, 2019 | 11.63M |
| June 30, 2019 | 11.12M |
| March 31, 2019 | 10.79M |
| December 31, 2018 | 9.639M |
| September 30, 2018 | 9.525M |
| June 30, 2018 | 9.834M |
| March 31, 2018 | 9.005M |
| December 31, 2017 | 9.192M |
| September 30, 2017 | 12.84M |
| June 30, 2017 | 11.39M |
| March 31, 2017 | 10.24M |
| December 31, 2016 | 9.065M |
| September 30, 2016 | 8.123M |
| June 30, 2016 | 7.950M |
| March 31, 2016 | 7.634M |
| December 31, 2015 | 7.761M |
| September 30, 2015 | 5.500M |
| June 30, 2015 | 5.312M |
| March 31, 2015 | |
| December 31, 2014 | 7.520M |
| September 30, 2014 | 4.772M |
| June 30, 2014 | 6.345M |
| January 31, 2014 | 0.0419M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.437M |
| Shareholders Equity (Quarterly) | 3.925M |
| Current Ratio | 8.665 |